AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will provide a brief overview of the company followed by a question and answer period with investors at the following investor conferences during the month of February:
- February 16, at 9:30 a.m. ET – Leerink Swann 2012 Global Healthcare Conference in New York City; and
- February 27, at 11:30 a.m. ET – Citi 2012 Global Healthcare Conference in New York City.
A live webcast of each presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit www.amagpharma.com.